Skip to main content

Cisplatin (NCT04107077)

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer: a one-minute explainerNCT041070771 min

Cisplatin trial for Gastric Cancer (NCT04107077). This is a short film with English narration. The transcript is on this page, and the written brief is separate.

What the film says

Read the transcript

This trial is for adults with gastric cancer involving the peritoneum or cancer cells in abdominal fluid, after systemic chemotherapy. Spread beyond the peritoneum and nearby lymph nodes is excluded.

The idea: give heated cisplatin and mitomycin directly into the abdomen through laparoscopy. Up to two procedures occur about six weeks apart, with doses adjusted if needed. Researchers primarily test whether this changes PD-L1 expression in tumor samples. Benefit is not established.

This phase 2 study plans 21 patients. Ardaman Shergill leads it at the University of Chicago, the sole recruiting US site.

Public record; not medical advice.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.